Reportlinker Adds Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global hematology market. The report provides market landscape, competitive landscape and market trends information on the hematology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include hemostasis, hematology reagents, immunohematology, haematology rapid tests, hematology analyzers and hematology cell counters.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within hematology market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Beckman Coulter, Sysmex Corporation, F. Hoffmann-La Roche Ltd. (Roche), Siemens Healthcare and Abbott Laboratories.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the hematology market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the hematology market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global hematology market and the factors shaping it.
1 Table of contents
1 Table of contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 GlobalData Report Guidance 9
3 Hematology: Device Overview 10
3.1 Hemostasis 10
3.2 Hematology Reagents 10
3.3 Immunohematology 11
3.4 Hematology Rapid Tests 11
3.5 Hematology Analyzers 11
3.6 Hematology Cell Counters 12
4 Disorders Detected using Hematology Diagnostics 13
4.1 Blood Disorders 13
4.1.1 Anemia 13
4.1.2 Leukemia 14
4.1.3 Lymphoma 14
4.1.4 Bleeding and Clotting Disorders 15
5 Hematology: Global Market Characterization 15
5.1 Hematology Market, Global, Revenue ($m), Historic, 2003–2010 15
5.2 Hematology Market, Global, Revenue ($m), Forecast, 2010–2017 16
5.3 Hematology Market, Key Trends 17
5.3.1 Increasing Automation in Laboratories is a Key Trend in the Diagnostic Hematology Market 17
5.3.2 Point of Care Testing and Development of Support Technologies is a Major Trend in Hematology Market 18
5.4 Hematology, Market Dynamics 20
5.4.1 Market Drivers 21
5.5 Market Restraints 27
5.6 Hematology Market, Global, Company Share (%), 2009 29
6 Hematology Market, Segment Analysis 30
6.1 Hemostasis, Global, Revenue ($m), Historic, 2003–2010 30
6.2 Hemostasis, Global, Revenue ($m), Forecast, 2010–2017 31
6.3 Hemostasis, Market Dynamics 32
6.3.1 Market Drivers 32
6.3.2 Market Restraint: High Price and Low Profit Margins of Coagulation Analyzers are the Key Restraints for the Hemostasis Market 32
6.4 Hematology Reagents, Global, Revenue ($m), Historic, 2003–2010 33
6.5 Hematology Reagents, Global, Revenue ($m), Forecast, 2010–2017 34
6.6 Hematology Reagents, Market Dynamics 35
6.6.1 Market Driver: Increasing Number of Installed Automated Hematology Analyzers is Driving the Market of Hematology Reagents 35
6.6.2 Market Restraint: Increasing Usage of Sensor based POC Blood Analyzers are Acting as a Restraint for Hematology Reagents Market 35
6.7 Immunohematology, Global, Revenue ($m), Historic, 2003–2010 36
6.8 Immunohematology, Global, Revenue ($m), Forecast, 2010–2017 37
6.9 Immunohematology, Market Dynamics 38
6.9.1 Market Driver: Increasing Awareness of Blood Donation Resulting in ABO Typing and Antibody Detection is Driving the Immunohematology Market 38
6.9.2 Market Restraint: Immunohematology Market is Affected by Lack of Skilled Workers and Infrastructure 38
6.10 Hematology Rapid Tests, Global, Revenue ($m), Historic, 2003–2010 39
6.11 Hematology Rapid Tests, Global, Revenue ($m), Forecast, 2010–2017 40
6.12 Hematology Rapid Tests, Market Dynamics 41
6.12.1 Market Driver: Increasing Anemia Disease Population is Driving the Hematology Rapid Tests Diagnostic Market 41
6.12.2 Market Restraint: Automated and POCT Devices are Expected to Replace Rapid Test Kits as a Preferred Choice of Hematology Rapid Tests 41
6.13 Hematology Analyzers, Global, Revenue ($m), Historic, 2003–2010 42
6.14 Hematology Analyzers, Global, Revenue ($m), Forecast, 2010–2017 43
6.15 Hematology Analyzers, Market Dynamics 44
6.15.1 Market Driver: Automation and High Volume Testing is Acting as a Driver for the Market of Hematology Analyzers 44
6.15.2 Market Restraint: High Pricing has a Negative Impact on the Acceptance of Automated Hematology Analyzers 44
6.16 Hematology Cell Counters, Global, Revenue ($m), Historic, 2003–2010 44
6.17 Hematology Cell Counters, Global, Revenue ($m), Forecast, 2010–2017 46
6.18 Hematology Cell Counters, Market Dynamics 47
6.18.1 Market Driver: Manual Blood Counting Chambers and Hemoglobinometers are still in Demand in Rural Diagnostic Centers of Countries such as India 47
6.18.2 Market Restraint: Automated Hematology Analyzers are Expected to Replace Manual Counting Chambers as a Preferred Choice of Hematology Cell Counters 47
7 Hematology Market, by Country, Revenue ($m), 2003–2017 48
7.1 Hematology Market, the US, Revenue ($m), Historic, 2003–2010 48
7.2 Hematology Market, the US, Revenue ($m), Forecast, 2010–2017 49
7.3 Hematology Market, Canada, Revenue ($m), Historic, 2003–2010 50
7.4 Hematology Market, Canada, Revenue ($m), Forecast, 2010–2017 51
7.5 Hematology Market, the UK, Revenue ($m), Historic, 2003–2010 52
7.6 Hematology Market, the UK, Revenue ($m), Forecast, 2010–2017 53
7.7 Hematology Market, Germany, Revenue ($m), Historic, 2003–2010 54
7.8 Hematology Market, Germany, Revenue ($m), Forecast, 2010–2017 55
7.9 Hematology Market, France, Revenue ($m), Historic, 2003–2010 56
7.10 Hematology Market, France, Revenue ($m), Forecast, 2010–2017 57
7.11 Hematology Market, Italy, Revenue ($m), Historic, 2003–2010 58
7.12 Hematology Market, Italy, Revenue ($m), Forecast, 2010–2017 59
7.13 Hematology Market, Spain, Revenue ($m), Historic, 2003–2010 60
7.14 Hematology Market, Spain, Revenue ($m), Forecast, 2010–2017 61
7.15 Hematology Market, Japan, Revenue ($m), Historic, 2003–2010 62
7.16 Hematology Market, Japan, Revenue ($m), Forecast, 2010–2017 63
7.17 Hematology Market, China, Revenue ($m), Historic, 2003–2010 63
7.18 Hematology Market, China, Revenue ($m), Forecast, 2010–2017 65
7.19 Hematology Market, India, Revenue ($m), Historic, 2003–2010 66
7.20 Hematology Market, India, Revenue ($m), Forecast, 2010–2017 67
7.21 Hematology Market, Australia, Revenue ($m), Historic, 2003–2010 68
7.22 Hematology Market, Australia, Revenue ($m), Forecast, 2010–2017 69
7.23 Hematology Market, Brazil, Revenue ($m), Historic, 2003–2010 70
7.24 Hematology Market, Brazil, Revenue ($m), Forecast, 2010–2017 71
8 Hematology Market: Strategic Competitive Assessment 72
8.1 Hematology Market, Key Market Participants 73
8.1.1 Beckman Coulter, Inc. 73
8.1.2 Sysmex Corporation 77
8.1.3 F. Hoffmann-La Roche Ltd. 80
8.1.4 Siemens Healthcare 84
8.1.5 Abbott Laboratories 87
9 Hematology Market: Key Marketed Products 90
9.1 The i-STAT System – Hand Held Hematology Analyzer by Abbott Laboratories 90
9.1.1 Product Description 90
9.1.2 Features and Benefits 90
9.2 Cobas b 221 System by Roche Diagnostics 91
9.2.1 Product Description 91
9.2.2 Features and Benefits 91
9.3 XE-AlphaN Automated Hematology System by Sysmex Corporation. 92
9.3.1 Product Description 92
9.3.2 Features and Benefits 92
9.4 UniCel DxH 800 Coulter Cellular Analysis System by Beckman Coulter, Inc. 93
9.4.1 Product Description 93
9.4.2 Features, Advantages and Benefits 93
9.5 PFA-100 Hemostasis System by Siemens Healthcare 94
9.5.1 Product Description 94
9.5.2 Features and Benefits 94
10 Hematology Market: Strategic Pipeline Assessment 95
10.1 Hematology Market: Pipeline Products Summary 95
10.2 Profiles of Promising Hematology Products Under Clinical Development 96
10.2.1 BrightSPOT Hematology Analyzer by Beacon Biotechnology 96
10.2.2 Point of Care Testing Device by Biomerieux Sa 97
10.2.3 BC-6800 Hematology Analyzer by Mindray Medical International Limited 97
10.2.4 Cobas b 123 Point of Care (POC) blood gas System by Roche Diagnostics Limited 98
10.2.5 ADVIA 120 Hematology System –IRF, MPC and MPM Tests by Siemens Healthcare 99
11 Hematology Market: Mergers and Acquisitions (M&A) Landscape 100
11.1 Hematology Market: Key Acquisitions, 2007–2010 102
11.1.1 Danaher to Acquire Beckman Coulter, Inc. for $6.8 Billion 102
11.1.2 Erba Diagnostics Mannheim Acquires Diasis Diagnostic Systems 102
11.1.3 Bio-Rad Laboratories Completes Acquisition of Medical Diagnostics Segment from Biotest 103
11.1.4 Grifols Acquires Medion Diagnostics 103
11.1.5 Danaher Completes Acquisition of Genetix Group 104
11.1.6 CCS Capital Acquires Beijing Biochem Hengye Science & Technology Development Co., Ltd. 104
12 Appendix 105
12.1 Definitions 105
12.1.1 Hematology 105
12.1.2 Hemostasis 105
12.1.3 Hematology Reagents 106
12.1.4 Immunohematology 106
12.1.5 Hematology Rapid Tests 106
12.1.6 Hematology Analyzers 106
12.1.7 Hematology Cell Counters 106
12.2 Acronyms 107
12.3 Sources 108
12.4 Research Methodology 108
12.5 Secondary Research 108
12.6 Primary Research 109
12.7 Models 109
12.8 Forecasts 109
12.9 Expert Panels 110
12.10 GlobalData Consulting 110
12.11 Contact Us 110
12.12 Disclaimer 110
1.1 List of Tables
Table 1: Hematology Market, Global, Revenue ($m), 2003–2010 16
Table 2: Hematology Market, Global, Revenue ($m), 2010–2017 17
Table 3: Hematology Market, Emerging Economies (China, India, Brazil), Revenue ($m), 2003–2017 22
Table 4: Projected Percentage of the US Population Aged 65 and Over, 2000–2050 25
Table 5: Hematology Market, Global, Company Share (%), 2009 29
Table 6: Hemostasis Market, Global, Revenue ($m), 2003–2010 30
Table 7: Hemostasis Market, Global, Revenue ($m), 2010–2017 31
Table 8: Hematology Reagents Market, Global, Revenue ($m), 2003–2010 33
Table 9: Hematology Reagents Market, Global, Revenue ($m), 2010–2017 34
Table 10: Immunohematology Market, Global, Revenue ($m), 2003–2010 36
Table 11: Immunohematology Market, Global, Revenue ($m), 2010–2017 37
Table 12: Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010 39
Table 13: Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017 40
Table 14: Hematology Analyzers Market, Global, Revenue ($m), 2003–2010 42
Table 15: Hematology Analyzers Market, Global, Revenue ($m), 2010–2017 43
Table 16: Hematology Cell Counters Market, Global, Revenue ($m), 2003–2010 45
Table 17: Hematology Cell Counters Market, Global, Revenue ($m), 2010–2017 46
Table 18: Hematology Market, the US, Revenue ($m), 2003–2010 48
Table 19: Hematology Market, the US, Revenue ($m), 2010–2017 49
Table 20: Hematology Market, Canada, Revenue ($m), 2003–2010 50
Table 21: Hematology Market, Canada, Revenue ($m), 2010–2017 51
Table 22: Hematology Market, the UK, Revenue ($m), 2003–2010 52
Table 23: Hematology Market, the UK, Revenue ($m), 2010–2017 53
Table 24: Hematology Market, Germany, Revenue ($m), 2003–2010 54
Table 25: Hematology Market, Germany, Revenue ($m), 2010–2017 55
Table 26: Hematology Market, France, Revenue ($m), 2003–2010 56
Table 27: Hematology Market, France, Revenue ($m), 2010–2017 57
Table 28: Hematology Market, Italy, Revenue ($m), 2003–2010 58
Table 29: Hematology Market, Italy, Revenue ($m), 2010–2017 59
Table 30: Hematology Market, Spain, Revenue ($m), 2003–2010 60
Table 31: Hematology Market, Spain, Revenue ($m), 2010–2017 61
Table 32: Hematology Market, Japan, Revenue ($m), 2003–2010 62
Table 33: Hematology Market, Japan, Revenue ($m), 2010–2017 63
Table 34: Hematology Market, China, Revenue ($m), 2003–2010 64
Table 35: Hematology Market, China, Revenue ($m), 2010–2017 65
Table 36: Hematology Market, India, Revenue ($m), 2003–2010 66
Table 37: Hematology Market, India, Revenue ($m), 2010–2017 67
Table 38: Hematology Market, Australia, Revenue ($m), 2003–2010 68
Table 39: Hematology Market, Australia, Revenue ($m), 2010–2017 69
Table 40: Hematology Market, Brazil, Revenue ($m), 2003–2010 70
Table 41: Hematology Market, Brazil, Revenue ($m), 2010–2017 71
Table 42: Hematology Marketed Products, Beckman Coulter, Inc., 2011 73
Table 43: Beckman Coulter, Inc., Pipeline Products, 2011 74
Table 44: Hematology Marketed Products, Sysmex Corporation, 2011 77
Table 45: Hematology Marketed Products, F. Hoffmann-La Roche Ltd., 2011 81
Table 46: F. Hoffmann-La Roche Ltd., Pipeline Products, 2011 81
Table 47: Hematology Marketed Products, Siemens Healthcare, 2011 84
Table 48: Siemens Healthcare, Pipeline Products, 2011 85
Table 49: Hematology Marketed Products, Abbott Laboratories, 2011 87
Table 50: i-STAT System – Hand Held Hematology Analyzer, Features and Benefits 90
Table 51: Cobas b 221 system, Features and Benefits 91
Table 52: XE-AlphaN Automated Hematology System, Features and Benefits 92
Table 53: UniCel DxH 800 Coulter Cellular Analysis System, Features and Benefits 93
Table 54: PFA-100 Hemostasis System, Features and Benefits 94
Table 55: Hematology Market, Global, Pipeline Assessment, by category, 2011 95
Table 56: BrightSPOT Hematology Analyzer, Product Status, 2011 96
Table 57: Point Of Care Testing Device, Product Status, 2011 97
Table 58: BC-6800 Hematology Analyzer, Product Status, 2011 97
Table 59: Cobas b 123 POC System, Product Status, 2011 98
Table 60: Advia 2120 Hematology System - IRF, MPC, MPM Tests, Product Status, 2011 99
Table 61: Hematology Market, Mergers and Acquisitions, by Volume, Global, 2007–2011* 101
1.2 List of Figures
Figure 1: Hematology Market, Global, Revenue ($m), 2003–2010 15
Figure 2: Hematology Market, Global, Revenue ($m), 2010–2017 16
Figure 3: Hematology, Market Dynamics, Global 20
Figure 4: US Healthcare Insurance System, 2011 21
Figure 5: Essential Components of Diagnosis Related Group (DRG) System 23
Figure 6: Projected Percentage of the US Population Aged 65 and Over, 2000–2050 25
Figure 7: Hematology Market, Global, Company Share (%), 2009 29
Figure 8: Hemostasis Market, Global, Revenue ($m), 2003–2010 30
Figure 9: Hemostasis Market, Global, Revenue ($m), 2010–2017 31
Figure 10: Hematology Reagents Market, Global, Revenue ($m), 2003–2010 33
Figure 11: Hematology Reagents Market, Global, Revenue ($m), 2010–2017 34
Figure 12: Immunohematology Market, Global, Revenue ($m), 2003–2010 36
Figure 13: Immunohematology Market, Global, Revenue ($m), 2010–2017 37
Figure 14: Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010 39
Figure 15: Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017 40
Figure 16: Hematology Analyzers Market, Global, Revenue ($m), 2003–2010 42
Figure 17: Hematology Analyzers Market, Global, Revenue ($m), 2010–2017 43
Figure 18: Hematology Cell Counters Market, Global, Revenue ($m), 2003–2010 44
Figure 19: Hematology Cell Counters Market, Global, Revenue ($m), 2010–2017 46
Figure 20: Hematology Market, the US, Revenue ($m), 2003–2010 48
Figure 21: Hematology Market, the US, Revenue ($m), 2010–2017 49
Figure 22: Hematology Market, Canada, Revenue ($m), 2003–2010 50
Figure 23: Hematology Market, Canada, Revenue ($m), 2010–2017 51
Figure 24: Hematology Market, the UK, Revenue ($m), 2003–2010 52
Figure 25: Hematology Market, the UK, Revenue ($m), 2010–2017 53
Figure 26: Hematology Market, Germany, Revenue ($m), 2003–2010 54
Figure 27: Hematology Market, Germany, Revenue ($m), 2010–2017 55
Figure 28: Hematology Market, France, Revenue ($m), 2003–2010 56
Figure 29: Hematology Market, France, Revenue ($m), 2010–2017 57
Figure 30: Hematology Market, Italy, Revenue ($m), 2003–2010 58
Figure 31: Hematology Market, Italy, Revenue ($m), 2010–2017 59
Figure 32: Hematology Market, Spain, Revenue ($m), 2003–2010 60
Figure 33: Hematology Market, Spain, Revenue ($m), 2010–2017 61
Figure 34: Hematology Market, Japan, Revenue ($m), 2003–2010 62
Figure 35: Hematology Market, Japan, Revenue ($m), 2010–2017 63
Figure 36: Hematology Market, China, Revenue ($m), 2003–2010 63
Figure 37: Hematology Market, China, Revenue ($m), 2010–2017 65
Figure 38: Hematology Market, India, Revenue ($m), 2003–2010 66
Figure 39: Hematology Market, India, Revenue ($m), 2010–2017 67
Figure 40: Hematology Market, Australia, Revenue ($m), 2003–2010 68
Figure 41: Hematology Market, Australia, Revenue ($m), 2010–2017 69
Figure 42: Hematology Market, Brazil, Revenue ($m), 2003–2010 70
Figure 43: Hematology Market, Brazil, Revenue ($m), 2010–2017 71
Figure 44: Hematology Market, Competitive Assessment, 2011 72
Figure 45: Beckman Coulter, Inc., SWOT Analysis, 2011 75
Figure 46: Sysmex Corporation, SWOT Analysis, 2011 79
Figure 47: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2011 82
Figure 48: Siemens Healthcare, SWOT Analysis, 2011 85
Figure 49: Abbott Laboratories, SWOT Analysis, 2011 88
Figure 50: Hematology Market, Mergers and Acquisitions, by Value and Volume, Global, 2007–2011* 100Beckman Coulter, Inc.
Sysmex Corporation
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article